1. Home
  2. GPOR vs KTTA Comparison

GPOR vs KTTA Comparison

Compare GPOR & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gulfport Energy Corporation

GPOR

Gulfport Energy Corporation

HOLD

Current Price

$214.57

Market Cap

4.1B

Sector

Energy

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.14

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPOR
KTTA
Founded
1997
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
5.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GPOR
KTTA
Price
$214.57
$1.14
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$229.78
$3.00
AVG Volume (30 Days)
220.4K
9.6M
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,231,668,000.00
N/A
Revenue This Year
$57.83
N/A
Revenue Next Year
$9.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.91
N/A
52 Week Low
$153.27
$0.28
52 Week High
$225.78
$3.85

Technical Indicators

Market Signals
Indicator
GPOR
KTTA
Relative Strength Index (RSI) 60.24 56.38
Support Level $198.83 $1.02
Resistance Level $209.94 $1.21
Average True Range (ATR) 4.34 0.09
MACD 0.18 -0.02
Stochastic Oscillator 98.54 36.97

Price Performance

Historical Comparison
GPOR
KTTA

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: